HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Mohty Selected Research

Hyperglycemia

8/2016How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Mohty Research Topics

Disease

21Leukemia
01/2020 - 03/2004
18Multiple Myeloma
05/2024 - 07/2004
18Graft vs Host Disease (Graft-Versus-Host Disease)
11/2021 - 09/2004
11Neoplasms (Cancer)
11/2017 - 08/2001
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 03/2004
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2024 - 03/2009
7Lymphoma (Lymphomas)
03/2016 - 04/2000
6Infections
04/2016 - 11/2003
5Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2018 - 06/2015
4Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2017 - 08/2012
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2017 - 01/2011
4Pathologic Complete Response
12/2012 - 03/2009
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 01/2015
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 10/2012
3Hodgkin Disease (Hodgkin's Disease)
10/2016 - 08/2012
3Residual Neoplasm
12/2015 - 12/2012
3Hematologic Neoplasms (Hematological Malignancy)
01/2015 - 08/2012
2Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 02/2017
2Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2021 - 02/2017
2Hematologic Diseases (Blood Diseases)
04/2016 - 02/2005
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
03/2016 - 02/2015
2Inflammation (Inflammations)
03/2016 - 07/2013
2Thrombocytopenia (Thrombopenia)
12/2015 - 01/2000
2Invasive Fungal Infections
10/2012 - 03/2007
1Fibrosis (Cirrhosis)
10/2017
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
06/2017
1Hepatocellular Carcinoma (Hepatoma)
03/2017
1Renal Cell Carcinoma (Grawitz Tumor)
03/2017
1Mucositis
02/2017
1Hyperglycemia
08/2016
1Glucose Intolerance
08/2016
1Diabetes Mellitus
08/2016
1Brain Neoplasms (Brain Tumor)
04/2016
1Breast Neoplasms (Breast Cancer)
04/2016
1Temporal Lobe Epilepsy
04/2016

Drug/Important Bio-Agent (IBA)

5Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2015 - 07/2004
4Busulfan (Busulfex)FDA Link
09/2017 - 07/2004
3fludarabineIBA
09/2017 - 07/2004
3Lenalidomide (CC 5013)FDA Link
04/2016 - 02/2010
3HLA Antigens (Human Leukocyte Antigens)IBA
09/2015 - 11/2010
2Chimeric Antigen ReceptorsIBA
05/2024 - 01/2022
2SteroidsIBA
10/2017 - 10/2012
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2016 - 12/2015
2Rituximab (Mabthera)FDA Link
09/2016 - 10/2012
2Interleukin-22 (IL-22)IBA
03/2016 - 07/2013
2Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2015 - 09/2004
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
12/2015 - 09/2004
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2014 - 04/2005
2Thalidomide (Thalomid)FDA Link
02/2005 - 01/2005
1fenixIBA
05/2024
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
05/2024
1idecabtagene vicleucelIBA
05/2024
1B-Cell Maturation AntigenIBA
05/2024
1Immunosuppressive Agents (Immunosuppressants)IBA
11/2021
1HLA-A Antigens (HLA-A)IBA
01/2021
1HLA-DQB1 antigen (HLA DQB1)IBA
01/2021
1C-Reactive ProteinIBA
10/2017
1Gemtuzumab (Mylotarg)FDA Link
04/2017
1Sorafenib (BAY 43-9006)FDA Link
03/2017
1Janus Kinase InhibitorsIBA
02/2017
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
02/2017
1elotuzumabIBA
01/2017
1Monoclonal AntibodiesIBA
01/2017
1PanobinostatIBA
01/2017
1daratumumabIBA
01/2017
1pomalidomideIBA
01/2017
1ixazomibIBA
01/2017
1carfilzomibIBA
01/2017
1Brentuximab VedotinIBA
10/2016
1ErbB Receptors (EGF Receptor)IBA
04/2016
1gallium 68 PSMA-11IBA
04/2016
123-seleno-25-homotaurocholic acidIBA
04/2016
1Dictyostelium severin protein (severin)IBA
04/2016
1lipoarabinomannan (LAM)IBA
04/2016
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
04/2016
1N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
04/2016
1melanin-concentrating hormone receptorIBA
04/2016
1multidrug resistance-associated protein 1IBA
04/2016
1fluorocholineIBA
04/2016
1fluoromethylcholineIBA
04/2016
15-(2-fluoroethyl) 2,4- diethyl- 3- (ethylsulfanylcarbonyl)- 6- phenylpyridine- 5- carboxylateIBA
04/2016
1radium Ra 223 dichlorideIBA
04/2016
1Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2016
1AcidsIBA
04/2016
1AerosolsIBA
04/2016
1Carbon MonoxideIBA
04/2016
1Choline (Choline Chloride)IBA
04/2016
1Ciprofloxacin (Cipro)FDA LinkGeneric
04/2016
1Dihydroxyphenylalanine (Dopa)IBA
04/2016

Therapy/Procedure

37Stem Cell Transplantation
01/2018 - 11/2003
30Transplantation
01/2020 - 08/2000
19Therapeutics
05/2024 - 08/2001
14Hematopoietic Stem Cell Transplantation
06/2017 - 03/2009
12Cell Transplantation
01/2024 - 04/2012
9Drug Therapy (Chemotherapy)
09/2016 - 03/2001
5Homologous Transplantation
12/2015 - 08/2001
4Salvage Therapy
04/2014 - 01/2005
2Organ Transplantation
08/2016 - 07/2007
1Radioimmunotherapy
11/2017
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2016